EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Mucus production and chronic obstructive pulmonary disease, a possible treatment target: zooming in on N-acetylcysteine

Federico Baraldi iD, Tommaso Bigoni iD, Maria Pia Foschino Barbaro, Claudio Micheletto iD, Giulia Scioscia iD, Alessandro Vatrella iD, Alberto Papi iD

Monaldi Archives for Chest Disease · 2025

DOI: 10.4081/monaldi.2025.3159 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Monaldi Archives for Chest Disease, 2025. Verfasst von Federico Baraldi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Section of Respiratory Medicine, Department of Translational Medicine, University of Ferrara. Hauptthemen laut MEDLINE: Acetylcysteine, Pulmonary Disease, Chronic Obstructive, Mucus. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucus hypersecretion is a trait of chronic obstructive pulmonary disease (COPD) associated with poorer outcomes. As it may be present before airway obstruction, its early treatment may have a preventive role. This narrative review of the literature presents the role of mucus dysfunction in COPD, its pathophysiology, and the rationale for the use of N-acetylcysteine (NAC). NAC can modify mucus rheology, improving clearance and reducing damage induced MUC5AC expression. It exerts a direct and indirect (glutathione replenishment) antioxidant mechanism; it interferes with inflammatory molecular pathways, including inhibition of nuclear factor-kB activation in epithelial airway cells and reduction in the expression of cytokine tumor necrosis factor α, interleukin (IL)-6, and IL-10. Some clinical experiences suggest that the adjunctive use of NAC may reduce symptoms and improve outcomes for patients with COPD. In conclusion, NAC may be a candidate drug for the early treatment of subjects at risk of COPD development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetylcysteinePulmonary Disease, Chronic ObstructiveMucusHumansAntioxidantsMucin 5ACExpectorants

Stichwörter der Autor:innen

COPDN-acetylcysteinechronic bronchitismucus hyperproduction

Substanzen

AcetylcysteineAntioxidantsMucin 5ACMUC5AC protein, humanExpectorants

Autor:innen und Institutionen

  • Section of Respiratory Medicine, Department of Translational Medicine, University of Ferrara.
  • Section of Respiratory Medicine, Department of Translational Medicine, University of Ferrara; Respiratory Unit, ULSS 8 Berica, Vicenza.
  • Department of Medical and Surgical Sciences, University of Foggia.
  • Respiratory Unit, Integrated University Hospital of Verona.
  • Department of Medical and Surgical Sciences, University of Foggia; Respiratory Medicine, Policlinico of Foggia.
  • Department of Medicine, Surgery and Dentistry, University of Salerno.

ORCID-Profile: Federico Baraldi, Tommaso Bigoni, Claudio Micheletto, Giulia Scioscia, Alessandro Vatrella, Alberto Papi

Zitieren

APA

Baraldi, F., Bigoni, T., Foschino Barbaro, M. P., Micheletto, C., Scioscia, G., Vatrella, A., & Papi, A. (2025). Mucus production and chronic obstructive pulmonary disease, a possible treatment target: zooming in on N-acetylcysteine. Monaldi Archives for Chest Disease. https://doi.org/10.4081/monaldi.2025.3159

Vancouver

Baraldi F, Bigoni T, Foschino Barbaro MP, Micheletto C, Scioscia G, Vatrella A, et al. Mucus production and chronic obstructive pulmonary disease, a possible treatment target: zooming in on N-acetylcysteine. Monaldi Archives for Chest Disease. 2025. doi:10.4081/monaldi.2025.3159

BibTeX
@article{Baraldi2025,
  author = {Baraldi, Federico and Bigoni, Tommaso and Foschino Barbaro, Maria Pia and Micheletto, Claudio and Scioscia, Giulia and Vatrella, Alessandro and Papi, Alberto},
  title = {Mucus production and chronic obstructive pulmonary disease, a possible treatment target: zooming in on N-acetylcysteine},
  journal = {Monaldi Archives for Chest Disease},
  year = {2025},
  doi = {10.4081/monaldi.2025.3159}
}
Kostenlos starten →